WO2001083031A3 - Topical composition for the treatment of psoriasis and related skin disorders - Google Patents
Topical composition for the treatment of psoriasis and related skin disorders Download PDFInfo
- Publication number
- WO2001083031A3 WO2001083031A3 PCT/US2001/014011 US0114011W WO0183031A3 WO 2001083031 A3 WO2001083031 A3 WO 2001083031A3 US 0114011 W US0114011 W US 0114011W WO 0183031 A3 WO0183031 A3 WO 0183031A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- psoriasis
- treatment
- glucosamine
- formulations
- related skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01932815A EP1278574B1 (en) | 2000-05-01 | 2001-05-01 | Topical composition for the treatment of psoriasis and related skin disorders |
DE60136348T DE60136348D1 (en) | 2000-05-01 | 2001-05-01 | TOPICAL COMPOSITION FOR THE TREATMENT OF PSORIASIS AND RELATED SKIN DISEASES |
AU2001259311A AU2001259311B2 (en) | 2000-05-01 | 2001-05-01 | Topical composition for the treatment of psoriasis and related skin disorders |
NZ522709A NZ522709A (en) | 2000-05-01 | 2001-05-01 | Topical composition for the treatment of psoriasis and related skin disorders comprising glucosamine and herbal extracts of berberine and oleuropein |
MXPA02010799A MXPA02010799A (en) | 2000-05-01 | 2001-05-01 | Topical composition for the treatment of psoriasis and related skin disorders. |
IL152592A IL152592A (en) | 2000-05-01 | 2001-05-01 | Topical composition for the treatment of psoriasis and related skin disorders |
AU5931101A AU5931101A (en) | 2000-05-01 | 2001-05-01 | Topical composition for the treatment of psoriasis and related skin disorders |
NO20025263A NO331668B1 (en) | 2000-05-01 | 2002-11-01 | Topical skin preparation for the treatment of psoriasis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/562,400 | 2000-05-01 | ||
US09/562,400 US6440465B1 (en) | 2000-05-01 | 2000-05-01 | Topical composition for the treatment of psoriasis and related skin disorders |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/221,344 A-371-Of-International US6759971B2 (en) | 2000-09-13 | 2001-09-06 | Trainline controller electronics |
US10/845,089 Division US6980127B2 (en) | 2000-09-13 | 2004-05-14 | Trainline controller electronics |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001083031A2 WO2001083031A2 (en) | 2001-11-08 |
WO2001083031A3 true WO2001083031A3 (en) | 2002-04-11 |
Family
ID=24246147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/014011 WO2001083031A2 (en) | 2000-05-01 | 2001-05-01 | Topical composition for the treatment of psoriasis and related skin disorders |
Country Status (11)
Country | Link |
---|---|
US (2) | US6440465B1 (en) |
EP (1) | EP1278574B1 (en) |
AT (1) | ATE412417T1 (en) |
AU (2) | AU2001259311B2 (en) |
CZ (1) | CZ303216B6 (en) |
DE (1) | DE60136348D1 (en) |
IL (1) | IL152592A (en) |
MX (1) | MXPA02010799A (en) |
NO (1) | NO331668B1 (en) |
NZ (1) | NZ522709A (en) |
WO (1) | WO2001083031A2 (en) |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7816402B2 (en) * | 1999-03-19 | 2010-10-19 | Bioderm, Inc. | Compositions and methods for the treatment of skin |
US6217914B1 (en) * | 1999-03-19 | 2001-04-17 | Bioderm, Inc. | Ascorbic acid composition and method for treatment of aging or damaged skin |
GB0002952D0 (en) * | 2000-02-09 | 2000-03-29 | Pharma Mar Sa | Process for producing kahalalide F compounds |
FR2808191B1 (en) * | 2000-04-28 | 2004-03-05 | Oreal | PLANT EXTRACT OF THE SPECIES OLEA EUROPAEA AS NO-SYNTHASE INHIBITOR AND USES |
US6440465B1 (en) * | 2000-05-01 | 2002-08-27 | Bioderm, Inc. | Topical composition for the treatment of psoriasis and related skin disorders |
ES2392706T5 (en) * | 2000-09-01 | 2018-02-07 | Creagri, Inc. | Procedure for obtaining a composition rich in hydroxytyrosol from vegetation water |
US7713569B2 (en) * | 2000-09-01 | 2010-05-11 | Creagri, Inc. | Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof |
AU2002311985B9 (en) * | 2001-05-23 | 2008-07-10 | Raquel Castellon | Methods for inhibiting angiogenesis |
US7901713B2 (en) * | 2001-06-20 | 2011-03-08 | Metaproteomics, Llc | Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops |
US7270835B2 (en) * | 2001-06-20 | 2007-09-18 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7205151B2 (en) * | 2001-06-20 | 2007-04-17 | Metaproteomics, Llc | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
US7901714B2 (en) * | 2001-06-20 | 2011-03-08 | Metaproteomics, Llp | Treatment modalities for autoimmune diseases |
US7815944B2 (en) * | 2001-06-20 | 2010-10-19 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity |
US7718198B2 (en) * | 2001-06-20 | 2010-05-18 | Metaproteomics, Llc | Treatment modalities for autoimmune diseases |
US20040115290A1 (en) * | 2001-06-20 | 2004-06-17 | Tripp Matthew L. | Modulation of inflammation by hops fractions and derivatives |
US8206753B2 (en) * | 2001-06-20 | 2012-06-26 | Metaproteomics, Llc | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
US8168234B2 (en) | 2001-06-20 | 2012-05-01 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US8142819B2 (en) * | 2002-10-21 | 2012-03-27 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
US20050054555A1 (en) * | 2001-10-19 | 2005-03-10 | Jose Jimeno | Kahalalide compounds for use in cancer therapy |
US8158160B2 (en) | 2001-11-13 | 2012-04-17 | Eric Hauser Kuhrts | Anti-inflammatory cyclooxygenase inhibitors |
WO2003068171A2 (en) * | 2002-02-13 | 2003-08-21 | Creagri, Inc. | Method and composition for treatment of inflammation and aids-associated neurological disorders |
DE10213019A1 (en) * | 2002-03-22 | 2003-10-02 | Cognis Deutschland Gmbh | Use of extracts from the olive tree as an antidandruff agent |
BG65352B1 (en) * | 2002-05-16 | 2008-03-31 | "Софарма" Ад | Means for psoriasis treatment |
US7468355B2 (en) * | 2002-05-22 | 2008-12-23 | H2Rc Corporation | Methods for inhibiting cancer and scar formation |
GB0304367D0 (en) * | 2003-02-26 | 2003-04-02 | Pharma Mar Sau | Methods for treating psoriasis |
EP1558271A4 (en) * | 2002-10-21 | 2006-01-11 | Metaproteomics Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7429396B2 (en) * | 2003-02-25 | 2008-09-30 | Bio-Botanica, Inc. | Antifungal composition, its fungicidal effect on pathogenic dermatophytes, and process for inhibiting growth of fungi |
US7507708B2 (en) * | 2003-02-26 | 2009-03-24 | Pharma Mar, S.A.U. | Antitumoral compounds |
FR2853549B1 (en) * | 2003-04-11 | 2007-11-09 | Agronomique Inst Nat Rech | NUTRITIONAL OR THERAPEUTIC COMPOSITION CONTAINING THE OLEUROPE COMPOUND OR ONE OF ITS DERIVATIVES |
AU2004283065B2 (en) * | 2003-05-22 | 2009-11-26 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
US8633246B2 (en) * | 2003-08-11 | 2014-01-21 | Hill's Pet Nutrition, Inc. | Omega-3 fatty acids for osteoarthritis |
US8633247B2 (en) * | 2003-08-11 | 2014-01-21 | Hill's Pet Nutrition, Inc. | Method for decreasing cartilage damage in dogs |
US20050042306A1 (en) * | 2003-08-21 | 2005-02-24 | Christopher Marrs | Stabilized compositions containing an oxygen-labile active agent |
US20050042233A1 (en) * | 2003-08-21 | 2005-02-24 | Christopher Marrs | Stabilized compositions containing an oxygen-labile active agent and a fungal extract |
US7205006B2 (en) * | 2003-09-25 | 2007-04-17 | Prime Pharmaceutical Corporation | Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same |
US20050152996A1 (en) * | 2003-12-01 | 2005-07-14 | BUTLER Donald | Extracts of Mimulus aurantiacus for treating psoriasis and repelling insects |
US7914831B2 (en) | 2004-02-27 | 2011-03-29 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
US20050192356A1 (en) * | 2004-02-27 | 2005-09-01 | Babish John G. | Synergistic anti-inflammatory pharmaceutical compositions and methods of use |
US20080025948A1 (en) * | 2004-03-10 | 2008-01-31 | Chih-Ping Liu | Methods of Treatment Using Interferon-Tau |
GB0408958D0 (en) * | 2004-04-22 | 2004-05-26 | Pharma Mar Sa | Convergent synthesis for kahalalide compounds |
JP2008509224A (en) * | 2004-08-09 | 2008-03-27 | クレアグリ, インコーポレイテッド | Olive compositions and methods for treating inflammatory conditions |
US20090010863A1 (en) * | 2004-10-19 | 2009-01-08 | The Boots Company Plc | Cosmetic Compositions |
WO2006138056A1 (en) * | 2005-06-15 | 2006-12-28 | Apollo Pharmaceutical, Inc. | Pharmaceutical composition comprising a mahonia aquifolium extract for the treatment of psoriasis |
US9789149B2 (en) | 2005-07-19 | 2017-10-17 | Creagri, Inc. | Vegetation water composition for treatment of inflammatory skin conditions |
US20080248131A1 (en) * | 2005-08-09 | 2008-10-09 | Metaproteomics, Llc | Protein Kinase Modulation by Hops and Acacia Products |
US8697152B2 (en) * | 2005-08-31 | 2014-04-15 | Johnson & Johnson Consumer Companies, Inc. | Anti-inflammatory compositions and personal care compositions comprising olive leaf (Olea europea) extract |
US8758838B2 (en) * | 2005-08-31 | 2014-06-24 | Johnson & Johnson Consumer Companies, Inc. | Anti-inflammatory compositions and methods of use |
US20070116778A1 (en) * | 2005-11-22 | 2007-05-24 | Fierro Arthur A | Antibacterial, antiviral, and antifungal nutritional supplement: a combination of natural or neutraceutical compounds shown to have antibacterial, antiviral, and antifungal properties, to help boost the immune system in humans, and to protect against certain biowarfare diseases |
AU2006321727A1 (en) * | 2005-12-09 | 2007-06-14 | Metaproteomics, Llc | Protein kinase modulation by hops and Acacia products |
CN101460060A (en) * | 2006-03-01 | 2009-06-17 | 特莱斯特拉塔公司 | Composition and method for topical treatment of tar-responsive dermatological disorders |
US20080124404A1 (en) * | 2006-06-19 | 2008-05-29 | Jingwen Liu | Hypolipidemic and/or hypocholesteremic compounds obtainable from the goldenseal plant |
US20080051466A1 (en) * | 2006-06-20 | 2008-02-28 | Metaproteomics, Llc | Isoalpha acid based protein kinase modulation cancer treatment |
KR20090023722A (en) * | 2006-06-20 | 2009-03-05 | 메타프로테오믹스, 엘엘씨 | Tetrahydro-isoalpha acid based protein kinase modulation cancer treatment |
JP5339373B2 (en) * | 2006-07-14 | 2013-11-13 | ディーエスエム アイピー アセッツ ビー.ブイ. | Composition and its use for the treatment, co-treatment or prevention of inflammatory disorders |
US20080057138A1 (en) * | 2006-09-06 | 2008-03-06 | Telford Holdings Ltd. | Restorative skin cream |
JP2010506908A (en) * | 2006-10-20 | 2010-03-04 | スーヨル キム, | Composition for treating atopic dermatitis containing glucosamine or glucosamine derivative and method for treating atopic dermatitis using the same |
JP5175481B2 (en) * | 2006-10-23 | 2013-04-03 | エーザイフード・ケミカル株式会社 | Cartilage regeneration promoter |
KR100834444B1 (en) | 2007-01-15 | 2008-06-09 | 원광대학교산학협력단 | Pharmaceutical composition comprising oleuropein isolated from fraxinus rhynchophylla for prevention and treating toxoplasmosis |
US8815306B2 (en) * | 2007-03-19 | 2014-08-26 | Metaproteomics, Llc | Methods and compositions for promoting bone and joint health |
NZ581064A (en) | 2007-05-11 | 2012-12-21 | Metaproteomics Llc | Methods and compositions for heavy metal detoxification |
WO2009032215A1 (en) * | 2007-08-29 | 2009-03-12 | Creagri, Inc. | Food and beverage supplement |
FR2924349B1 (en) | 2007-12-03 | 2010-01-01 | Dbv Tech | ALLERGEN DISENSIBILITY METHOD |
MX2010006425A (en) * | 2007-12-10 | 2010-08-31 | Metaproteomics Llc | Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith. |
CA2720546A1 (en) * | 2008-04-02 | 2009-10-08 | Metaproteomics, Llc. | Substituted 1,3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions |
ES2711927T3 (en) * | 2009-03-13 | 2019-05-08 | Dbv Tech | Method to treat eczema |
ES2349976B1 (en) * | 2009-05-14 | 2011-11-10 | Sanidad Y Residencias 21 Sa | USE OF OLIVE LEAF EXTRACTS IN A PHARMACEUTICAL COMPOSITION TO INDUCE ANGIOGENESIS AND VASCULOGENESIS. |
CN102481290A (en) | 2009-06-30 | 2012-05-30 | 德安生医有限公司 | Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders |
CN104940225A (en) * | 2009-08-24 | 2015-09-30 | 谭国梁 | Medicine capable of dissolving and eliminating lesion tissues and pathogens |
IT1395509B1 (en) * | 2009-09-02 | 2012-09-28 | Bionap Srl | COMPOSITION FOR THE TREATMENT OF HEMORROIDARY PATHOLOGY AND RELATED PATHOLOGIES |
JP2013521300A (en) * | 2010-03-03 | 2013-06-10 | ネオキュティス エスアー | Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds |
US8545904B1 (en) | 2012-06-05 | 2013-10-01 | Liquid Innovators, LLC | Topical composition containing Carapa (andiroba) oil for psoriasis and other related dermatological disorders |
TW201538156A (en) | 2013-12-19 | 2015-10-16 | Twi Biotechnology Inc | Berberine formulations and uses thereof |
US20160263092A1 (en) | 2013-12-19 | 2016-09-15 | Twi Biotechnology, Inc. | Therapeutic uses of berberine formulations |
KR101567735B1 (en) * | 2014-12-09 | 2015-11-09 | 동국대학교 산학협력단 | Composition for preventing or improving or treating psoriasis comprising immunomodulating agent and glucosamine |
TW201713334A (en) | 2015-06-24 | 2017-04-16 | 安成生物科技股份有限公司 | Therapeutic uses of berberine formulations |
US9867827B1 (en) | 2015-08-27 | 2018-01-16 | Florida A&M University | Methods and formulations for topical treatment of psoriasis |
US20230270762A1 (en) * | 2020-07-17 | 2023-08-31 | Bioderm, Inc. | Topical composition for the treatment of psoriasis and related skin disorders |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4473551A (en) * | 1982-08-23 | 1984-09-25 | Faxon Pharmaceuticals, Inc. | Anti-inflammatory composition |
EP0281812A1 (en) * | 1987-02-18 | 1988-09-14 | Milor Scientific, Ltd. | Composition for treatment of acne |
FR2732215A1 (en) * | 1995-03-28 | 1996-10-04 | Sederma Sa | Skin-lightening cosmetic compsns. |
US5795573A (en) * | 1998-01-08 | 1998-08-18 | Paradise; Lou | Homeopathic pharmaceutical compositions |
WO1998042309A1 (en) * | 1997-03-25 | 1998-10-01 | Crandall Wilson T | Topical moisturizing composition and method |
WO1998042348A1 (en) * | 1997-03-25 | 1998-10-01 | Wilson Trafton Crandall | Topical moisturizing composition and method |
WO2000000186A1 (en) * | 1998-06-30 | 2000-01-06 | American Medical Research, Inc. | Method of treating topical ailments |
WO2001017495A1 (en) * | 1999-09-09 | 2001-03-15 | The Boots Company Plc | Skincare composition against free radicals |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3232836A (en) * | 1959-08-24 | 1966-02-01 | Pfizer & Co C | Facilitating healing of body surface wounds by intravenous administration of n-acetyl glucosamine, glucosamine, or pharmaceutically acceptable acid salts of glucosamine |
US3122535A (en) * | 1961-06-02 | 1964-02-25 | Benckiser Gmbh Joh A | 5-nitro furfurylidene-d-glucosamine, and process of making same |
US4294852A (en) | 1973-11-01 | 1981-10-13 | Johnson & Johnson | Skin treating compositions |
US4102995A (en) | 1976-05-13 | 1978-07-25 | Westwood Pharmaceuticals Inc. | Tar gel formulation |
US4722936A (en) | 1983-05-05 | 1988-02-02 | Joseph Jacob | Deodorization vaginal products and catamenials |
US4711780A (en) | 1984-06-11 | 1987-12-08 | Fahim Mostafa S | Composition and process for promoting epithelial regeneration |
US4647453A (en) | 1984-10-18 | 1987-03-03 | Peritain, Ltd. | Treatment for tissue degenerative inflammatory disease |
US4818521A (en) | 1985-04-18 | 1989-04-04 | Sunstar Kabushiki Kaisha | Emulsion cosmetic stably containing vitamin C |
US4772591A (en) | 1985-09-25 | 1988-09-20 | Peritain, Ltd. | Method for accelerated wound healing |
US4983382A (en) | 1987-01-27 | 1991-01-08 | Avon Products, Inc. | Cosmetic preparation incorporating stabilized ascorbic acid |
US4938969A (en) | 1988-11-14 | 1990-07-03 | Milor Scientific, Ltd. | Method for the treatment of aging or photo-damaged skin |
DE3843238C1 (en) | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
US5140043A (en) | 1989-04-17 | 1992-08-18 | Duke University | Stable ascorbic acid compositions |
US5554647A (en) | 1989-10-12 | 1996-09-10 | Perricone; Nicholas V. | Method and compositions for treatment and/or prevention of skin damage and aging |
FR2658509B1 (en) * | 1990-02-22 | 1992-06-12 | Roussel Uclaf | |
US5308621A (en) | 1991-02-18 | 1994-05-03 | Commonwealth Scientific And Industrial Research Organisation | Ascorbic acid composition and transdermal administration method |
JP2609564B2 (en) * | 1991-05-31 | 1997-05-14 | 政夫 斎藤 | Cream for allergic dermatitis and method for producing the same |
AU667519B2 (en) * | 1992-02-07 | 1996-03-28 | Albert M. Kligman | Methods of treating inflammatory dermatoses |
DE4221537A1 (en) | 1992-07-01 | 1994-01-05 | Schwabe Willmar Gmbh & Co | Dry witch hazel extract, process for its preparation and its use as a medicine |
US5391373A (en) * | 1992-07-01 | 1995-02-21 | Chanel, Inc. | Skin cream composition |
NL9201438A (en) * | 1992-08-11 | 1994-03-01 | Prospa Bv | Novel pharmaceutical compositions comprising esters of omega-3 polyunsaturated acids and their use in the topical treatment of ailments. |
US5310742A (en) * | 1992-11-30 | 1994-05-10 | Elias Alan N | Uses for thioureylenes |
US5516793A (en) | 1993-04-26 | 1996-05-14 | Avon Products, Inc. | Use of ascorbic acid to reduce irritation of topically applied active ingredients |
DE4328871A1 (en) * | 1993-08-27 | 1995-03-02 | Beiersdorf Ag | Means against sensitive, hyper-reactive skin conditions, atopic dermatitis, pruritus, psoriasis prurigo, photodermatoses and ichthyosis |
CA2120967A1 (en) * | 1994-04-11 | 1995-10-12 | Boubaker Boussetta | Medicine for the treatment of psoriasis and skin diseases |
JP3294449B2 (en) | 1994-12-02 | 2002-06-24 | 花王株式会社 | Cell adhesion inhibitor |
US5639740A (en) * | 1995-03-10 | 1997-06-17 | Crandall; Wilson Trafton | Topical moisturizing composition and method |
GB9515214D0 (en) * | 1995-07-25 | 1995-09-20 | Univ Strathclyde | Plant extracts |
GB2307176A (en) * | 1995-11-15 | 1997-05-21 | Todd Selwyn Everest | Anti-inflammatory clathrating agents for topical use |
US6395772B1 (en) * | 1996-02-14 | 2002-05-28 | National Institute Of Immunology | Method for blocking endothelial cell-leukocyte attachment by inhibiting expression of adhesion molecules on the vascular endothelium for therapeutic applications |
US5804594A (en) | 1997-01-22 | 1998-09-08 | Murad; Howard | Pharmaceutical compositions and methods for improving wrinkles and other skin conditions |
FR2760637B1 (en) | 1997-03-11 | 1999-05-28 | Fabre Pierre Dermo Cosmetique | COAL TAR EXTRACT WITH REDUCED AROMATIC HYDROCARBON CONTENT, PROCESS FOR OBTAINING AND DERMO-COSMETIC PREPARATIONS |
US5902591A (en) | 1997-04-03 | 1999-05-11 | La Prairie Sa | Stable topical cosmetic/pharmaceutical emulsion compositions containing ascorbic acid |
WO1998052576A1 (en) * | 1997-05-21 | 1998-11-26 | New Key Foods N.V. | Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain |
IT1298283B1 (en) * | 1998-02-19 | 1999-12-20 | B & T S R L | USE OF THE EXTRACT OF EUROPEAN OIL LEAVES AS ANTI-RADICAL |
US6110966A (en) | 1998-02-20 | 2000-08-29 | Medi-Cell Laboratories, Inc. | Triple action complex |
US6217914B1 (en) | 1999-03-19 | 2001-04-17 | Bioderm, Inc. | Ascorbic acid composition and method for treatment of aging or damaged skin |
US7816402B2 (en) | 1999-03-19 | 2010-10-19 | Bioderm, Inc. | Compositions and methods for the treatment of skin |
US6011067A (en) * | 1999-06-11 | 2000-01-04 | Thione International, Inc. | Antioxidant composition for the treatment of psoriasis and related diseases |
US20050003023A1 (en) | 2002-06-28 | 2005-01-06 | Meisner Lorraine Faxon | Topical composition for the treatment of psoriasis and related skin disorders |
US6440465B1 (en) | 2000-05-01 | 2002-08-27 | Bioderm, Inc. | Topical composition for the treatment of psoriasis and related skin disorders |
-
2000
- 2000-05-01 US US09/562,400 patent/US6440465B1/en not_active Expired - Lifetime
-
2001
- 2001-05-01 EP EP01932815A patent/EP1278574B1/en not_active Expired - Lifetime
- 2001-05-01 CZ CZ20023854A patent/CZ303216B6/en not_active IP Right Cessation
- 2001-05-01 WO PCT/US2001/014011 patent/WO2001083031A2/en active IP Right Grant
- 2001-05-01 NZ NZ522709A patent/NZ522709A/en not_active IP Right Cessation
- 2001-05-01 MX MXPA02010799A patent/MXPA02010799A/en active IP Right Grant
- 2001-05-01 AU AU2001259311A patent/AU2001259311B2/en not_active Expired
- 2001-05-01 AU AU5931101A patent/AU5931101A/en active Pending
- 2001-05-01 IL IL152592A patent/IL152592A/en not_active IP Right Cessation
- 2001-05-01 AT AT01932815T patent/ATE412417T1/en not_active IP Right Cessation
- 2001-05-01 DE DE60136348T patent/DE60136348D1/en not_active Expired - Lifetime
-
2002
- 2002-06-28 US US10/185,388 patent/US7670620B2/en not_active Expired - Fee Related
- 2002-11-01 NO NO20025263A patent/NO331668B1/en not_active IP Right Cessation
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4473551A (en) * | 1982-08-23 | 1984-09-25 | Faxon Pharmaceuticals, Inc. | Anti-inflammatory composition |
EP0281812A1 (en) * | 1987-02-18 | 1988-09-14 | Milor Scientific, Ltd. | Composition for treatment of acne |
FR2732215A1 (en) * | 1995-03-28 | 1996-10-04 | Sederma Sa | Skin-lightening cosmetic compsns. |
WO1998042309A1 (en) * | 1997-03-25 | 1998-10-01 | Crandall Wilson T | Topical moisturizing composition and method |
WO1998042348A1 (en) * | 1997-03-25 | 1998-10-01 | Wilson Trafton Crandall | Topical moisturizing composition and method |
US5795573A (en) * | 1998-01-08 | 1998-08-18 | Paradise; Lou | Homeopathic pharmaceutical compositions |
WO2000000186A1 (en) * | 1998-06-30 | 2000-01-06 | American Medical Research, Inc. | Method of treating topical ailments |
WO2001017495A1 (en) * | 1999-09-09 | 2001-03-15 | The Boots Company Plc | Skincare composition against free radicals |
Also Published As
Publication number | Publication date |
---|---|
IL152592A0 (en) | 2003-05-29 |
CZ20023854A3 (en) | 2003-06-18 |
CZ303216B6 (en) | 2012-05-30 |
DE60136348D1 (en) | 2008-12-11 |
EP1278574B1 (en) | 2008-10-29 |
IL152592A (en) | 2008-12-29 |
NZ522709A (en) | 2005-07-29 |
NO20025263L (en) | 2002-12-19 |
EP1278574A2 (en) | 2003-01-29 |
AU5931101A (en) | 2001-11-12 |
WO2001083031A2 (en) | 2001-11-08 |
US20020164386A1 (en) | 2002-11-07 |
US6440465B1 (en) | 2002-08-27 |
NO331668B1 (en) | 2012-02-20 |
MXPA02010799A (en) | 2004-09-06 |
NO20025263D0 (en) | 2002-11-01 |
AU2001259311B2 (en) | 2005-12-08 |
US7670620B2 (en) | 2010-03-02 |
ATE412417T1 (en) | 2008-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001083031A3 (en) | Topical composition for the treatment of psoriasis and related skin disorders | |
CA2774026C (en) | Compositions comprising an anti-inflammatory blend | |
US4942033A (en) | Vegetable extract-based cosmetic or pharmaceutical composition which acts on capillary brittleness | |
US5871743A (en) | Topical application of soy molasses | |
DK2606874T3 (en) | Novel cosmetic and / or pharmaceutical compositions and their use / novel cosmetic and / or pharmaceutical Compositions and uses thereof | |
WO2004037184A3 (en) | Methods for the treatment of skin disorders | |
DE60122927D1 (en) | SKIN CREAM COMPOSITION | |
IE831611L (en) | Topical anti-inflammatory compositions | |
HRP20100485T1 (en) | Xanthoxyline-based composition and cosmetic use thereof | |
DK284386A (en) | PHARMACEUTICAL PREPARATION FOR SKIN DISORDERS | |
Nand et al. | In vitro and in vivo assessment of polyherbal topical gel formulation for the treatment of acne vulgaris | |
TW201805016A (en) | Novel SILYBUM MARIANUM achene extract and uses thereof in dermatology and dermo-cosmetics | |
JP4033981B2 (en) | Testosterone 5α-reductase inhibitor | |
TW201801738A (en) | Compositions including BAUHINIA, methods of making and using the same in skin anti-aging and other skin applications | |
WO2002072035A3 (en) | Novel anti-inflammatory compositions and methods of use | |
JP2001187742A (en) | Testosteron-5-alfa-reductase inhibitor | |
KR20060096130A (en) | Anti-inflammation composition including kanapanax cortex extract and ginger extract | |
IL157630A0 (en) | Pharmaceutical and cosmetic compositions for the protection of the skin from damages induced by sun radiations | |
KR102282645B1 (en) | Cosmetic composition comprising mixed extracts of cnidium officinale and scutellaria baicalensis or compounds seperated from thereof for alleiviating acne and dandruff | |
KR20050118820A (en) | The composition having the prevention of atopy | |
JPH11189540A (en) | Testosterone-5 alpha-reductase inhibitor | |
JPH0920644A (en) | Toilet lotion | |
JP2000256174A (en) | Cosmetic composition | |
Natakankitkul et al. | COSMECEUTICAL DEVELOPMENT OF OXYRESVERATROL FROM MAHAD (ARTOCARPUS LAKOOCHA ROXB.) | |
JP2003313116A (en) | Skin care preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2002/010799 Country of ref document: MX Ref document number: 152592 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001259311 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2002-3854 Country of ref document: CZ Ref document number: 522709 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001932815 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001932815 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV2002-3854 Country of ref document: CZ |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 522709 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 522709 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001259311 Country of ref document: AU |